content top

Adult Vitelliform Macular Dystrophy Treated with Bevacizumab

Naomi S. Falk, MD (Albany, NY), Paul M. Beer, MD (Albany, NY), Amjad M. Hammad, MD (Albany, NY) PURPOSE: To explore contrast between objective improvement and visual function. METHODS: Study design is a case report of a 55 year old woman who received 2 injections of intravitreal Bevacizumab for Adult Vitelliform dystrophy due to complaints of blurred vision and distortion. She had received 4 prior injections of Pegaptanib sodium without...

Read More

Six-month Follow-up on 50 Consecutive Patients with Intravitreal Bevacizumab Injections for Neovascular Age Related Macular Degeneration

http://www.evrs.eu/medias/2006/congress/Six-month-Follow-up-on-50-Consecutive-Patients-with-Intravitreal-Bevacizumab-Injections-for-Neovascular-Age-Related-Macular-Degeneration.swf Samira Khan, (Albany, NY), Paul M. Beer, MD (Albany, NY), Naomi S. Falk, MD (Albany, NY), Amjad Hammad, MD (Albany, NY), Martin O’Malley, MD (Albany, NY) PURPOSE: 6 months results of intravitreal Bevacizumab on patients with neovascular ARMD. METHODS: A...

Read More

Vitreous Levels of Unbound Bevacizumab and Unbound Vascular Endothelial Growth Factors in Two Human Subjects

http://www.evrs.eu/medias/2006/congress/Vitreous-Levels-of-Unbound-Bevacizumab-and-Unbound-Vascular-Endothelial-Growth-Factors-in-Two-Human-Subjects.swf Paul M. Beer, MD (Albany, NY), Susan Wong, PhD (Albany, NY), Naomi S. Falk, MD (Albany, NY), Amjad Hammad, MD (Albany, NY), Samira Khan, (Albany, NY), MartinO’Malley, MD (Albany, NY) PURPOSE: Determination of vitreous levels of unbound VEGF and unbound bevacizumab in two patients who...

Read More
content top